Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Multiple Sclerosis and Related Disorders
|
December 22, 2022
Diagnosis concealment is prevalent in MS, and associated with diagnosis experience
V M Leavitt, A M Kever, S M Weinstein, et al.
Multiple Sclerosis and Related Disorders
|
October 24, 2022
Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis
Korhan Buyukturkoglu, Jordan D Dworkin, Victor Leiva, et al.
Neurology
|
May 11, 2016
Brain reserve against physical disability progression over 5 years in multiple sclerosis
James F Sumowski, Maria A Rocca, Victoria M Leavitt, et al.
AIDS Research and Human Retroviruses
|
February 7, 1998
Characterization of a molecular clone of HIV type 2 infectious for Macaca nemestrina
G Kraus, A Radaelli, R Talbott, et al.
The Journal of Physical Chemistry. A
|
February 17, 2009
Addition of H2O and O2 to acetone and dimethylsulfoxide ligated uranyl(V) dioxocations
Christopher M Leavitt, Vyacheslav S Bryantsev, Wibe A de Jong, et al.
Science (New York, N.Y.)
|
January 24, 2012
Determination of noncovalent docking by infrared spectroscopy of cold gas-phase complexes
Etienne Garand, Michael Z Kamrath, Peter A Jordan, et al.
Genomics
|
June 30, 2000
Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes
P J Welch, E G Marcusson, Q X Li, et al.
The Journal of Physical Chemistry. A
|
September 23, 2014
Liquid hot NAGMA cooled to 0.4 K: benchmark thermochemistry of a gas-phase peptide
Christopher M Leavitt, Kevin B Moore, Paul L Raston, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 3, 2025
Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model
Leila Simani, Ceren Tozlu, Seonjoo Lee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 9, 2024
Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS
Marcus W Koch, Carlos Camara-Lemarroy, Eva Strijbis, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Multiple Sclerosis and Related Disorders
|
December 22, 2022
Diagnosis concealment is prevalent in MS, and associated with diagnosis experience
V M Leavitt, A M Kever, S M Weinstein, et al.
Multiple Sclerosis and Related Disorders
|
October 24, 2022
Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis
Korhan Buyukturkoglu, Jordan D Dworkin, Victor Leiva, et al.
Neurology
|
May 11, 2016
Brain reserve against physical disability progression over 5 years in multiple sclerosis
James F Sumowski, Maria A Rocca, Victoria M Leavitt, et al.
AIDS Research and Human Retroviruses
|
February 7, 1998
Characterization of a molecular clone of HIV type 2 infectious for Macaca nemestrina
G Kraus, A Radaelli, R Talbott, et al.
The Journal of Physical Chemistry. A
|
February 17, 2009
Addition of H2O and O2 to acetone and dimethylsulfoxide ligated uranyl(V) dioxocations
Christopher M Leavitt, Vyacheslav S Bryantsev, Wibe A de Jong, et al.
Science (New York, N.Y.)
|
January 24, 2012
Determination of noncovalent docking by infrared spectroscopy of cold gas-phase complexes
Etienne Garand, Michael Z Kamrath, Peter A Jordan, et al.
Genomics
|
June 30, 2000
Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes
P J Welch, E G Marcusson, Q X Li, et al.
The Journal of Physical Chemistry. A
|
September 23, 2014
Liquid hot NAGMA cooled to 0.4 K: benchmark thermochemistry of a gas-phase peptide
Christopher M Leavitt, Kevin B Moore, Paul L Raston, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 3, 2025
Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model
Leila Simani, Ceren Tozlu, Seonjoo Lee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 9, 2024
Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS
Marcus W Koch, Carlos Camara-Lemarroy, Eva Strijbis, et al.
Page
of 19